NCT03636503 2025-02-06Rituximab + Immunotherapy in Follicular LymphomaDana-Farber Cancer InstitutePhase 1 Terminated24 enrolled 25 charts
NCT03258008 2022-12-16Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal CancerM.D. Anderson Cancer CenterPhase 2 Terminated3 enrolled 7 charts
NCT02444793 2019-02-27A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid TumorsPfizerPhase 1 Terminated24 enrolled 34 charts